Jump Financial LLC Makes New $993,000 Investment in STERIS plc (NYSE:STE)

Jump Financial LLC bought a new position in STERIS plc (NYSE:STE) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 4,833 shares of the medical equipment provider’s stock, valued at approximately $993,000.

Other institutional investors have also recently bought and sold shares of the company. Guggenheim Capital LLC lifted its holdings in shares of STERIS by 67.2% during the 4th quarter. Guggenheim Capital LLC now owns 3,440 shares of the medical equipment provider’s stock worth $707,000 after acquiring an additional 1,383 shares during the period. XTX Topco Ltd bought a new position in shares of STERIS during the 4th quarter worth approximately $261,000. Barclays PLC boosted its stake in STERIS by 24.1% in the 4th quarter. Barclays PLC now owns 161,970 shares of the medical equipment provider’s stock valued at $33,295,000 after buying an additional 31,497 shares in the last quarter. Synovus Financial Corp boosted its stake in STERIS by 1.9% in the 4th quarter. Synovus Financial Corp now owns 18,698 shares of the medical equipment provider’s stock valued at $3,844,000 after buying an additional 344 shares in the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new position in STERIS during the fourth quarter worth $961,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Up 1.1 %

STE opened at $222.53 on Monday. STERIS plc has a 1-year low of $198.13 and a 1-year high of $248.24. The stock has a market capitalization of $21.86 billion, a PE ratio of 47.25 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $222.48 and a two-hundred day moving average price of $218.98.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS’s payout ratio is presently 48.41%.

Wall Street Analyst Weigh In

STE has been the topic of several recent analyst reports. Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, April 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Monday, April 7th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.